David A. Siegel Catalyst Biosciences, Inc. Transaction History

Two Sigma Advisers, LP

$41.3 Billion
Q3 2024

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$0.49 - $1.95 $4,900 - $19,500	-10,000 Reduced 43.29%	13,100 $7,000
Q2 2022 Aug 15, 2022	SELL	$0.36 - $1.78 $1,404 - $6,942	-3,900 Reduced 14.44%	23,100 $41,000
Q1 2022 May 16, 2022	SELL	$0.51 - $1.0 $79,101 - $155,100	-155,100 Reduced 85.17%	27,000 $18,000
Q4 2021 Feb 14, 2022	BUY	$0.91 - $4.16 $68,341 - $312,416	75,100 Added 70.19%	182,100 $166,000
Q3 2021 Nov 15, 2021	SELL	$3.78 - $5.18 $173,502 - $237,762	-45,900 Reduced 30.02%	107,000 $440,000
Q2 2021 Aug 16, 2021	SELL	$4.1 - $5.33 $397,699 - $517,010	-97,000 Reduced 38.82%	152,900 $662,000
Q1 2021 May 17, 2021	SELL	$4.93 - $7.15 $411,162 - $596,310	-83,400 Reduced 25.02%	249,900 $1.26 Million
Q4 2020 Feb 16, 2021	BUY	$4.55 - $7.29 $185,640 - $297,432	40,800 Added 13.95%	333,300 $2.1 Million
Q3 2020 Nov 16, 2020	BUY	$4.22 - $6.04 $18,990 - $27,180	4,500 Added 1.56%	292,500 $1.26 Million
Q2 2020 Aug 14, 2020	BUY	$3.76 - $8.01 $356,824 - $760,149	94,900 Added 49.15%	288,000 $1.69 Million
Q1 2020 May 15, 2020	BUY	$3.5 - $8.51 $190,400 - $462,944	54,400 Added 39.22%	193,100 $844,000
Q4 2019 Feb 14, 2020	BUY	$4.52 - $7.91 $242,723 - $424,767	53,700 Added 63.18%	138,700 $945,000
Q3 2019 Nov 14, 2019	SELL	$4.91 - $9.31 $105,074 - $199,234	-21,400 Reduced 20.11%	85,000 $417,000
Q2 2019 Aug 14, 2019	SELL	$7.08 - $10.6 $24,780 - $37,100	-3,500 Reduced 3.18%	106,400 $784,000
Q1 2019 May 15, 2019	SELL	$7.67 - $9.96 $22,243 - $28,884	-2,900 Reduced 2.57%	109,900 $891,000
Q4 2018 Feb 14, 2019	SELL	$6.59 - $11.28 $48,107 - $82,344	-7,300 Reduced 6.08%	112,800 $890,000
Q3 2018 Nov 14, 2018	BUY	$9.35 - $12.44 $142,120 - $189,088	15,200 Added 14.49%	120,100 $1.3 Million
Q2 2018 Aug 14, 2018	BUY	$9.11 - $28.88 $955,638 - $3.03 Million	104,900 New	104,900 $1.22 Million

Others Institutions Holding CBIO

# of Institutions

Shares Held

215

Call Options Held

Put Options Held

American Portfolios Advisors Holbrook, NY

215
Shares

$0
0.0% of portfolio

View Full List

About CATALYST BIOSCIENCES, INC.

Ticker CBIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 31,477,100
Description
Catalyst Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on developing protease product candidates in the fields of hemostasis and complement regulation. The company's protease engineering platform creates improved or novel molecules to treat diseases that result from dysregulation of the complement system. It develops CB ...

More about CBIO

Track David A. Siegel's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Advisers, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Advisers, LP and David A. Siegel with notifications on news.

Account